Epigallocatechin gallate (EGCG) has regulatory effects on cellular immunity. The present study explored whether EGCG inhibits the overload-induced cardiac extracellular matrix (ECM) remodeling through targeting the balance of T cell subpopulations. Sprague-Dawley rats were subjected to either transverse aortic constriction (TAC) or sham operation. TAC rats were treated with EGCG or valsartan (Val) for 6 weeks. The administration of EGCG or Val ameliorated the overproduction of cardiac collagen, inhibited matrix metalloproteinase (MMP) activity, decreased the expression of tissue inhibitor of MMP-2, atrial natriuretic peptide and brain natriuretic peptide. EGCG regulated the population of effector T cells and naïve T cells, restored the balance of T helper (Th) cell 17/regulatory T cells, via modulating the downstream regulator signal transducer and activator of transcription (STAT3) and STAT5. Furthermore, the ratio of interferon-γ/interleukin (IL)-10 which indicates the balance of Th1/Th2, was restored by the treatments at varying degrees. EGCG and Val administration rescued IL-7 production, and decreased the level of IL-15 in TAC rats. EGCG has positive therapeutic potential in inhibiting cardiac ECM remodeling. Regulation of the balance of T lymphocyte subsets may be one of the underlying mechanisms responsible for this effect.
Introduction
Cardiac extracellular matrix (ECM) remodeling is the most severe clinical manifestations during the process of heart failure (HF), which is characterized by myocytes hypertrophy, excessive expansion and accumulation of ECM, less compliance, and matrix metalloproteinases (MMPs) activation (1) . Inflammation is evidently involved in adverse cardiac remodeling and HF. Accumulating evidences have shown that the elevated levels of pro-inflammatory cytokines including interleukin-6 (IL-6) and IL-17, are significantly correlated with the development of HF, especially with the ECM deposit (2) . Chronic IL-6 stimulation results in hypertrophy and dysfunction of left ventricular (LV), accordingly, depletion of IL-6 could effectively prevent LV hypertrophy induced by the infusion of angiotensin II (AngII) (3) . Besides the production of cytokines, the imbalance of the CD4 + T-helper (Th) lymphocytes subtypes Th1/Th2, later the imbalance of Th17/regulatory T (Treg) has been reported in the inflammatory microenvironment. The ratios of T-bet/GATA-3 and IFN-γ/IL-4 were markedly up-regulated in C57BL/6 mice treated with alcohol than that of the control group, suggesting that activating a Th2-type immune response is one of the underlying mechanisms of alcohol-induced cardiac remodeling (4) . Treatments that raise the expression of IL-10, a Th2 cytokine, have been reported to be a promising therapeutic strategy to prevent the progress of pressure overload-induced adverse cardiovascular remodeling (5) . Specifically, T lymphocytes were accepted to play a critical role both in the noncardiac tissues remodeling processes, and cardiac ECM remodeling and HF. Therefore, medications effectively control inflammation and T cell balance in the heart may provide therapeutic benefits (6) .
Green tea was used to treat various diseases in the traditional Chinese medicine. Later people realized that Epigallocatechin gallate (EGCG) is the major catechin in green tea and is regarded to have strong antioxidant activity, which may prevent cell damage, exert numerous protective effects on cancer growth, hyperlipidemia, diabetes, stroke, particularly on the cardiovascular system (7) (8) (9) . Green tea consumers have lower death risk from cardiovascular diseases. A recent meta-analysis of 18 published studies revealed that the mortality of cardiovascular diseases decreased by 5% if the patients' green tea consumption increased one cup per day (10 (11, 12) . Consequently, EGCG has been accepted as a potential novel approach for treating various cardiovascular diseases (13) . We reported recently that EGCG markedly inhibited the viability, proliferation and collagen production of myocytes induced by AngII (14) . EGCG may regulate cellular immunity as reported that EGCG could target Th cells and natural killer cell (15) . Thus, we hypothesized that EGCG inhibits the overload-induced ECM remodeling partially through regulating T cell subtypes and corresponding pro-inflammatory cytokines. Establishment of pressure overload-induced cardiac remodeling model and treatment. SD rats were randomly subjected to either transverse aortic constriction (TAC, to induce chronic pressure overload) or sham operation following the protocol described previously (16) . Briefly, the rats were anesthetized and the chest was opened, the intercostal muscles were then blunt dissected and followed by the identification of thoracic aorta, a 6.0 silk suture was placed around the transverse aorta, and a 26-gauge blunt needle was put parallel to the transverse aorta. To make a constriction, the needle was gently removed after the suture was tied. Sham-operated rats (n=10) underwent a similar surgical procedure without the ligation. TAC rats were randomly divided into a model group which was treated with vehicle; three EGCG-treatment groups (orally fed EGCG 25, 50 or 100 mg/kg B.W. day for 6 weeks) and Val-treatment group (orally fed Val 30 mg/kg B.W. day for 6 weeks) one week after the surgery.
Materials and methods

Animals
Masson's Trichrome staining of heart tissue. The hearts of rats were perfused with PBS and fixed in formalin and then were embedded in paraffin and sectioned into five-micron slices using Thermo HM355 Microtomes. The Masson's Trichrome staining was performed according to the instruction. The blue-stained areas in the sections were measured with Image J software (NIH, Bethesda, MD, USA) to evaluate the collagen deposition semi-quantitatively. The data from six regions of each heart was analyzed.
Determination of cardiac ECM. The micrograms of collagen per milligram of the dry heart were used to reflect the extent of cardiac ECM deposition. Since collagen contains about 13.5% hydroxyproline (17) , the level of total myocardial hydroxyproline was determined with the standard trans-hydroxyproline colorimetric curve (Sigma-Aldrich). Detection of Th17 cells. Splenic lyomphocytes were suspended in DMEM medium at a concentration of 1x10 7 cells/ml and were stimulated with PMA (final concentration is 50 ng/ml) and ionomycin (final concentration is 1 µM) for 5 h in the incubator. Golgistop (final concentration is 0.7 µl/ml) was added 1 h after culture. The subpopulation of Th17 (CD4 + IL-17 + ) cells was counted on an FC500 flow cytometer (Beckman Coulter) (18) .
Analysis of CD4
Determination of regulatory T cells (Tregs).
Isolated splenic lymphocytes (100 µl) (1x10 7 cells/ml) were stained with 0.125 µg anti-rat CD4-FITC and 0.06 µg anti-rat CD25-PE antibodies in the dark at 4˚C for 30 min. The cells were then fixed and permeabilized, blocked with 2% normal rat serum. 0.5 µg anti-mouse/rat Foxp3-PeCy5 antibody or rat IgG2a K isotype control PeCy5 was added to each sample without washing after the blocking step and incubated at 4˚C for 30 min in the dark. 100,000 cells were counted on FC500 flow cytometer (Beckman Coulter) (19) .
Determination of MMP activity. The activity of MMP was evaluated with an MMP activity assay kit. Briefly, 10 mg heart tissue was homogenized in 1 ml extraction buffer. Samples were spined and the supernatants were then incubated with equal volume of 2 mM p-Aminophenylmercuric acetate working (2x) solution for 15 min, then incubated with 50 µl MMP red substrate solution for 0 min (for kinetic reading) or 1 h (for end point reading), the fluorescence intensity was monitored with absorbance reader (ELx808, BioTek, US) and the MMP activity was analyzed as Ex/Em=540/590 nm.
The expression of TIMP-2, ANP, BNP, T-bet, GATA-3, RORC
and FoxP3 mRNA in heart tissue. The total RNA of splenic lymphocytes was extracted using the traditional TRIzol method. The primers used for qPCR are listed in Table I (20) .
Determination of serum IL-6, IL-7, IL-15, IL-17, IFN-γ, and IL-10.
Blood was centrifuged at 3000 x g for 30 min at 4˚C, and the serum was collected. IL-6, IL-7, IL-15, IL-17, IFN-γ and IL-10 levels were measured using ELISA kits. Absorbance values were read at 450 nm with an ELISA plate reader (ELx808; BioTek, Winooski, VT, USA) (21) .
Western blot analysis. Purified splenic lymphocytes were applied for western blot assay to detect the expression level of STAT3 and STAT5 following the conventional method. Briefly, the cells were lysed with RIPA buffer and the proteins were separated in a running gel. After the proteins had been transferred onto a PVDF membrane, the membrane was blocked in 5% fat-free milk and stained with anti-STAT3, anti-STAT5 or anti-β-actin primary antibody in 4˚C overnight, followed by the staining of secondary antibody. The membranes were then scanned using an imaging densitometer (GS-700; Bio-Rad, Berkeley, CA, USA). The images were quantified with ImageJ software (NIH).
Statistical analysis. At least triplicate determinations were made for each experiment. The representative results were shown in indicated cases. All data are expressed as the mean and standard deviation (SD). For multiple group comparisons, we used ANOVA and Tukey's post test. P<0.05 was considered to indicate a statistically significant difference.
Results
The effect of EGCG on cardiac fibrosis. Masson's Trichrome staining was applied to demonstrate the cardiac fibrosis and ECM deposition. As expected, EGCG 100 mg/kg or Val 30 mg/kg treatment effectively ameliorated the development of ventricular fibrosis (Fig. 1A) . The data was semi-quantified in Fig. 1B .
Collagen is a major component of the cardiac ECM, the amount of cardiac fiber detected by the determination of the total amount of hydroxyproline represents the expression level of collagen. As shown in Fig. 1C , the collagen contents in heart tissues from TAC rats were increased significantly compared with that of the sham-operated rats, the administration of EGCG (100 mg/kg) or Val (30 mg/kg) decreased total collagen content in overload-induced cardiac remodeling rats with various degrees. This result confirmed that EGCG is an effective preventer to against cardiac ECM accumulation. The mechanism is not clearly understood.
As shown in Fig. 1D , the MMPs activity in the cardiac tissue of overload-induced cardiac remodeling rats was evoked remarkably. The administration of EGCG to rats with TAC dose-dependently blocked the activity of MMPs. Val treatment slightly attenuated the increment of MMPs activity (P=0.038). The tissue inhibitor of metalloproteinases (TIMPs) specifically inhibit MMPs, we detected the mRNA level of TIMP-2 in heart tissue by qRT-PCR. TIMP-2 mRNA expression increased by 2.74 fold in TAC rats than that of normal rats. EGCG 50 and 100 mg/kg treatment, as well as Val administration significantly reduced the expression of TIMP-2 (Fig. 1E) .
Besides excessive expansion and accumulation of ECM, MMPs activation, ECM remodeling is also characterized by myocytes hypertrophy. ANP and BNP are common hypertrophic markers. As shown in Fig. 1F and G, ANP (2.503±0.456) and BNP (1.765±0.216) gene expression of the TAC rats was significantly upregulated, EGCG 50 and 100 mg/kg treatment and Val 30 mg/kg treatment markedly reduced both ANP and BNP expression.
The effect of EGCG on T cell activation. We found that T cells were activated and differentiated into CD4 + CD44 + effector T cells (Teff) in splenic lymphocytes from TAC rats, meanwhile, the population of CD4 + CD62L + naïve T cells (Tnaive) was diminished. EGCG (50, 100 mg/kg) treatment decreased the percentage of Teff subset and EGCG (100 mg/kg) rescued the subpopulation of Tnaive ( Fig. 2A and B) . As a result, EGCG restored the balance of Teff/Tnaive (Fig. 2C) , suggesting that it effectively inhibited T cells activation.
The effect of EGCG on the percentage of Th17 and Treg cells. Th17 cells were identified by expression of intracellular IL-17 and surface marker CD4 from rat spleens by flow cytometry (22) . It turned out that the percentages of Th17 cells represented a much higher value in overload-induced cardiac remodeling rats (13.4%) compared with the sham-operated rats (0.98%). As expected, Th17 subpopulation was substantially reduced in EGCG (50 mg/kg) (7.77%), EGCG (100 mg/kg) (3.32%) or Val (30 mg/kg) (5.63%) treatment groups (Fig. 3A) .
We next counted the subpopulation of Treg subsets by identifying the expression of nucleic transcriptional factor Foxp3 in CD4 + CD25 + rat splenic lymphocytes. Unlike the changes of Th17, the percentage of Treg cells was decreased obviously in rats with overload-induced cardiac remodeling (0.59±0.15%) compared with control rats (2.15±0.39%). The administration of EGCG (50 mg/kg) restored the content of Treg to 1.22±0.36%. In particular, the administration of EGCG (100 mg/kg) significantly increased the percentage of Treg cells (2.35±0.48%). Val exerted a similar effect as EGCG (1.29±0.28%, P=0.021) (Fig. 3B) . Comparingwith the sham rats, TAC group exhibited an increase in the ratio of Th17/Treg. EGCG (50, 100 mg/kg) and Val (30 mg/kg) 
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restored the imbalance of Th17/Treg ratio significantly (Fig. 3C) .
The effect of EGCG on the expressions of regulators for Th17 and Treg cells differentiation.
Besides the percentage determination, we further analyzed the expressions of transcription factor RORC for Th17 and FoxP3 for Treg cells, respectively. RORC encoding retinoid-related orphan receptor γt (RORγt) which is identified as the master transcription factor designating Th17 cell subpopulation. In accordance with the results of flow cytometry, we found RORC was upregulated in splenic lymphocytes from TAC rats, EGCG treatment restored its expression in a dose-dependent manner (Fig. 4A) . The polarization and maturation of Treg are tightly controlled by FoxP3, which expression was shown to be inhibited in the TAC group, EGCG and Val significantly rescued FoxP3 expression (Fig. 4B) . The differentiation of Th17 and Treg cells is mediated by downstream regulator STAT3 and STAT5 respectively (23) . As expected, the expression of STAT3 was substantially increased and STAT5 was obviously decreased in splenic lymphocytes of TAC mice. The administration of EGCG and Val was found to have distinct restorative effects on the expression of both regulators (Fig. 4C and D) . The effect of EGCG on the levels of serum Th1/Th2 cytokines. As shown in Fig. 5A , IL-7 expression was obviously reduced, while IL-15 level was increased in TAC rats comparing to that of normal rats. EGCG and Val administration restored IL-7 production, and decreased the level of IL-15 in TAC rats at different degrees. The concentrations of serum IL-6, IL-17, and IFN-γ were significantly elevated ( Fig. 5A and B) , while serum IL-10 was decreased in TAC rats (Fig. 5C) . EGCG (50 mg/kg) inhibited the upregulation of IL-6 and IFN-γ, EGCG (100 mg/kg) reduced the production of IL-6, IL-17 and IFN-γ, and the IL-10 synthesis was restored to almost the normal level. Similarly, Val treatment modulated the levels of serum IL-6, IL-17, IFN-γ and IL-10 with varying degrees. These data indicated that rats with overload-induced cardiac remodeling have more Th1 cytokine IFN-γ and less Th2 cytokine IL-10. Administration of EGCG or Val ameliorated the disequilibrium of IFN-γ/IL-10 ratio (Fig. 5D) , which suggests an imbalanced ratio of Th1/Th2 subsets, consequently improved disease symptoms.
Both Th1 and Th2 populations could be differentiated from naive Th cells, each of them has distinct functions and cytokine profiles (24) . Comparing with sham-operated control, the mRNA levels of T-bet, a T-box transcription factor required for Th1 cell development, in splenic lymphocytes from TAC rats was significantly increased (2 -ΔΔCq =18.34). The treatment of EGCG (100 mg/kg) or Val (30 mg/kg) mildly decreased T-bet gene expressions (Fig. 5E) . However, the level of GATA-3 mRNA, a critical regulator of Th2 polarization, was decreased in model rats. Oral administered EGCG (50, 100 mg/kg) or Val to TAC rats positively changed the GATA-3 mRNA expression (Fig. 5F ). In TAC model rats, the ratio of T-bet/GATA-3 was found to be elevated, which could be balanced by EGCG treatment (Fig. 5G) .
Discussion
In accordance with published articles, we observed that the collagen was accumulated in the heart of TAC rats, the MMPs were also found to be activated significantly, MMPs inhibitor TIMP-2 was induced simultaneously. The ECM may expand under microenvironmental stimuli including inflammatory cytokines (25) . The increased cardiac collagen expression paralleled to the ventricular stiffness was described by Badenhorst et al (26) . As expected, heart failure parameters ANP and BNP were elevated in TAC rats. In addition, Yu et al (27) reported that the ventricular stiffness is associated with T lymphocyte response in 2006, indicating that cellular immunity may contribute to ECM production. Consistently, we found T cells were activated, and the ratio of Teff/Tnaive was up-regulated in TAC rats.
The Th1/Th2 populations which are characterized based on the unique patterns of surface markers, cytokine profiles, and immune functions are induced by specific ligands. In chronic alcohol-induced cardiac fibrosis, alcohol consumption contributes to the imbalance of Th1/Th2 subsets with an increased Th2 activity (4). Th1 and Th17 cytokine productions were increased, and Th2 cytokine was reduced in Chagas disease cardiomyopathy (28) . Hypertensive rats induced by Ang II infusion were observed to have upregulation of IFN-γ (Th1 cytokine) and downregulation of IL-4 (Th2 cytokine) (29) . It was also reported that selectively induce Th1 leads to cardiac collagen deposit and collagen cross-linking, however, selectively induce Th2 subtype has the opposite effect in mice. As a result, the different Th cell phenotype distinctly influences the expression of pro-collagen and pro-MMP genes in cardiac fibroblasts (CFs), modulates the MMPs activity and collagen accumulation, contributes to the alteration of ECM composition, therefore, affects the diastolic function of the heart. Accordingly, regulation of the profile and function of Th lymphocyte could promote the adaptive ventricular remodeling in postmyocardial infarction and HF (6) . In the present study, we found the mRNA level of T-bet in splenic lymphocytes of TAC rats was significantly increased, however, the level of GATA-3 mRNA was decreased, and the ratio of T-bet/GATA-3 was elevated. In parallel with the expression of the transcription factor, IFN-γ (a Th1 cytokine) was elevated, while IL-10 (a Th2 cytokine) was diminished in the model rats. We illustrated that the imbalance of Th1/Th2 function exists in the cardiac remodeling process.
The homeostasis of T cells is regulated by two members of the common gamma chain family of cytokines, IL-7 and IL-15 (30) . Interestingly, in the present study, we observed an upregulation of serum IL-15 and a downregulation of serum IL-7 in TAC rats. Literature also reported that plasma IL-7 level dropped in chronic heart failure patients (31) . EGCG restored the homeostasis of T cells by rebalancing the expression of IL-7 and IL-15. IL-6 is considered an important cytokine in promoting the differentiation of Th17 cells from precursor Th cells. We revealed that in overload-induced cardiac remodeling rats, serum IL-6 production was increased significantly, resulting in the upregulation of both the percentage of Th17 and the level of IL-17. Previous studies have been conducted to exmine the role of IL-17 in inflammation-induced cardiac remodeling. It was reported that in IL-17-deficient mice, the interstitial myocardial fibrosis was attenuated, the expressions of MMP-2 and MMP-9 was reduced and the activity of gelatinase was inhibited. Anti-IL-17A monoclonal antibody could ameliorate both cardiac fibrosis and heart function when administered after the onset of myocarditis in BALB/c mice (32) . Th17 cells and Treg cells develop reciprocally from The levels of T-bet and GATA-3 mRNA were determined using quantitative real-time RT-PCR and the 2 -ΔΔCq method was applied to assess the mRNA levels (n=8). T-bet is a Th1-specific T box transcription factor. (F) GATA-3 is a critical regulator of Th2 polarization. Th17 population and the shrinking Treg population compared with the sham-operated controls, indicating that the imbalance of Th17/Treg ratio potentially involved in the pathogenesis of cardiac ECM remodeling, and restoring this balance may be a promising therapeutic approach to attenuate cardiac remodeling.
Evidence shows that EGCG has multiple protective effects against many kinds of cardiovascular diseases, including cardiac fibrosis. However, how does ECCG prevent collagen deposit in the heart is still unknown. Cai and colleagues recently reported that reducing collagen production, fibronectin (FN) expression, and CFs proliferation by inhibiting NF-κB activation in rats challenged with AngII is the underlying molecular mechanism of EGCG (34) . Besides cardiac fibrosis, EGCG is also a promising therapeutic drug for systemic sclerosis (SSc) induced oxidant stress and fibrosis (35) .
In the present series of studies, we investigated whether the inhibitory effects of EGCG on collagen accumulation and heart remodeling were associated with the modulation of T lymphocytes subsets. As shown in the results, EGCG reduced total collagen content and MMPs activity in remodeled cardiac tissue indicating EGCG is a potential treatment for preventing cardiac remodeling in rats with overload induced cardiac ECM remodeling. We further showed that EGCG augmented Th2 cytokine production and diminished Th1 and Th17 cytokine production, that is in accordance with the modulation of the expression of T-bet and GATA-3, which are the master regulators for Th1 and Th2 differentiation respectively. It also decreased Th17 and increased Treg populations in the spleen through restoring the expression of Th17 and Treg downstream regulators STAT3 and STAT5. Moreover, EGCG inhibited T cell activation by rebalanced the population of Teff and Tnaive.
In conclusion, based on the current studies, EGCG is proved to be an effective therapeutic natural medicine in treating cardiac ECM remodeling and improving heart function, and restoring the balances of Th1/Th2, Th17/Treg, Teff/Tnaive and regaining the immune homeostasis are the presumed mechanisms of its action.
